Pharmacokinetics, bioavailability and metabolism of rhaponticin in rat plasma by UHPLC-Q-TOF/MS and UHPLC-DAD-MS n

Bioanalysis

Volumn 4, Issue 6, 2012, Pages 713-723

  Zhao, Ying Yong ^a   Su, Qi ^a   Cheng, Xian Long ^b   Tan, Xiao Jie ^c   Bai, Xu ^c   Lin, Rui Chao ^b  

^a NORTHWEST UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Waters Technologies Shanghai Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RESVERATROL; RHAPONTIGENIN; RHAPONTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; IN VIVO STUDY; MALE; NONHUMAN; PROCESS OPTIMIZATION; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; MASS SPECTROMETRY; RATS; STILBENES;

EID: 84859123128     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.24     Document Type: Article

References (45)

1. Zhang R, Kang KA, Piao MJ et al. Rhapontigenin from Rheum undulatum protects against oxidative-stress-induced cell damage through antioxidant activity. J. Toxicol. Environ. Health 70(13), 1155-1166 (2007).
2. Matsuda H, Tomohiro N, Harima K et al. Study on anti-Oketsu activity on rhubarb II. Antiallergic effects of stilbene components from Rhei undulati Rhizoma (dried rhizome of Rheum undulatum cultivated in Korea). Biol. Pharm. Bull. 24(3), 264-267 (2001).
3. Kim DH, Park EK, Bae EA, Han MJ. Metabolism of rhaponticin and chrysophanol 8-O-glucopyranoside from the rhizome of Rheum undulatum by humam intestinal bacteria and their anti-allergic actions. Biol. Pharm. Bull. 23(7), 830-833 (2000).
4. Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg. Med. Chem. Lett. 10(4), 323-327 (2000).
5. Ryu SY, Choi SU, Lee CO, Lee SH, Ahn JW, Zee OP. Antitumor activity of some phenolic components in plants. Arch. Pharm. Res. 17(1), 42-44 (1994).
6. Misiti F, Sampaolese B, Mezzogori D et al. Protective effect of rhubarb derivatives on amyloid beta (1-42) peptide-induced apoptosis in IMR-32 cells: a case of nutrigenomic. Brain Res. Bull. 71(1-3), 29-36 (2006).
7. Hibasami H, Takagi K, Ishii T, Tsujikawa M, Imai N, Honad I. Induction of apoptosis by rhapontcin having stilbene moiety, a component of rhubarb (Rheum officinale Baillon) in human stomach cancer KATO III cells. Oncol. Rep. 18(2), 347-351 (2007).
8. Park EK, Choo MK, Yoon HK, Kim DH. Antithrombotic and antiallergic activities of rhaponticin from Rhei Rhizoma are activated by human intestinal bacteria. Arch. Pharm. Res. 25(4), 528-533 (2002).
9. Ngoc TM, Minh PTH, Hung TM et al. Lipoxygenase inhibitory constituents from rhubarb. Arch. Pharm. Res. 31(4), 598-605 (2008).
10. Yoo MY, Oh KS, Lee JW et al. Vasorelaxant effect of stilbenes from rhizome extract of rhubarb (Rheum undulatum) on the contractility of rat aorta. Phytother. Res. 21(2), 186-189 (2007).
11. Choi SB, Ko BS, Park SK, Jang JS, Park S. Insulin sensitizing and a-glucoamylase inhibitory action of sennosides, rheins and rhaponticin in Rhei Rhizoma. Life Sci. 78(9), 934-942 (2006).
12. Chen JL, Ma MM, Lu YW, Wang LS, Wu C. Duan HF. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice. Planta Med. 75(5), 472-477 (2009).
13. Wang LX, Zhang BC, Li LP, Zhou Z. Quantitative determination of rhapontin in root of Rheum hotaoense by TLC-scanning. China J. Chin. Mater. Med. 19(1), 37-62 (1994).
14. Xu LN, Han X, Qi Y et al. Multiple compounds determination and fingerprint analysis of Lidanpaishi tablet and keli by high-performance liquid chromatography. Anal. Chim. Acta 633(1), 136-148 (2009).
15. Gocan S. Analysis of stilbenes in wine by HPLC: recent approaches. J. Liq. Chromatogr. Related Technol. 32(11), 1598-1643 (2009).
16. Yi T, Leung KSY, Lu GH, Zhang H, Chan K. Identification and determination of the major constituents in traditional Chinese medicinal plant Polygonum multiflorum Thunb by HPLC coupled with PAD and ESI/MS. Phytochem. Anal. 18(3), 181-187 (2007).
17. Qu J, Xiao SY, Wang YM, Luo GA. Screening and identification of glycosides in biological samples using energy-gradient neutral loss scan and liquid chromatography tandem mass spectrometry. Anal. Chem. 76(8), 2239-2247 (2004).
18. Shang XY, Yuan ZB. Determination of six components in rhubarb by cyclodextrin-modified micellar electrokinetic chromatography using a mixed micellar system of sodium cholate and sodium taurocholate. Anal. Chim. Acta 456(2), 183-188 (2002).
19. Shang XY, Yuan ZB. Separation of effective constituents from rhubarb by micellar electrokinetic capillary chromatography. Anal. Lett. 35(1), 195-202 (2002).
20. Shang XY, Yuan ZB. Determination of active components in rhubarb and study of their hydrophobicity by micellar electrokinetic chromatography. Bioorg Med. Chem. Lett. 13(4), 617-622 (2003).
21. Shang XY, Yuan ZB. Separation and determination of active components in rhubarb by cyclodextrin-modified micellar electrokinetic chromatography using a mixed micellar system. Anal. Lett. 36(1), 203-214 (2003).
22. Hemingway RW, Hillis WE, Bruerton K. A gas-liquid chromatographic examination of stilbene derivatives. J. Chromatogr. A 50(1), 391-399 (1970).
23. Zhao YY, Wang LL, Miao H et al. LC method for the determination of rhaponticin in rat plasma, faeces and urine for application to pharmacokinetic studies. Chromatographia 73(5-6), 599-603 (2011). First paper to report a LC method for quantification of rhaponticin in rat plasma, faeces and urine.
24. Hsieh Y, Gaviz G, Hwa J. Ultra-performance hydrophilic interaction LC-MS-MS for the determination of metformin in mouse plasma. Bioanalysis 1(6), 1073-1079 (2009).
25. Marcelín-Jiménez G, Moreno Alionka CPA, Mendoza-Morales L, Rivera-Espinosa L, Martínez MM. Development of an ultra-performance liquid chromatography-tandem mass spectrometry micromethod for quantification of lamotrigine in human plasma and its use in a bioequivalence trial. Bioanalysis 1(1), 47-55 (2009).
26. Szapacs ME, Urbanski JJ, Kehler JR et al. Absolute quantification of a therapeutic domain antibody using ultra-performance liquid chromatography-mass spectrometry and immunoassay. Bioanalysis 2(1), 1597-1608 (2010).
27. Zhao YY, Qin XY, Cheng XL et al. Rapid resolution liquid chromatography-mass spectrometry and high-performance liquid chromatography-fluorescence detection for metabolism and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one. Anal. Chim. Acta 675(2), 199-206 (2010).
28. Zhao YY, Cheng XL, Liu R et al. Pharmacokinetics of ergosterol in rats using rapid resolution liquid chromatography-atmospheric pressure chemical ionization multi-stage tandem mass spectrometry and rapid resolution liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 879(21), 1945-1953 (2011).
29. Li F, Hsieh Y, Kang L et al. MALDI-tandem mass spectrometry imaging of astemizole and its primary metabolite in rat brain sections. Bioanalysis 1(2), 299-307 (2009).
30. Wrona M, Mauriala T, Bateman KP, Mortishire-Smith RJ, O'Connor D. 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole TOF mass spectrometry with collision energy switching. Rapid Commun. Mass Spectrom. 19 (18), 2597-2602 (2005).
31. Zhao YY, Cheng XL, Wei F et al. Serum metabonomics study of adenine-induced chronic renal failure rat by ultra performance liquid chromatography coupled with quadrupole TOF mass spectrometry. Biomarkers doi:10.3109/1354750X.637180 (2012) (Epub ahead of print).
32. Zhao YY, Liu J, Cheng XL, Bai X, Lin RC. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin. Chim. Acta 413(5-6), 642-649 (2012).
33. Zhao YY, Qin XY, Chen SP et al. Crystal and molecular structure of rhaponticin from Rheum hotaoense. J. Chem. Crystallogr. 41(3), 409-414 (2011).
34. U.S. Department of Health and Human Services, Food and Drug administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Centre (CVM). Guidance for industry: bioanalytical method validation (2001).
35. Zhao YY, Cheng XL, Zhang YM et al. A fast and sensitive HPLC-MS/MS analysis and preliminary pharmacokinetic characterization of ergone in rats. J. Chromatogr. B 878(1), 29-33 (2010).
36. Zhao YY, Qin XY, Zhang YM et al. Quantitative HPLC method and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one, a natural product with diuretic activity from Polyporus umbellatus. Biomed. Chromatogr. 24(10), 1120-1124 (2010).
37. Roupe KA, Helms GL, Halls SC, Yáñez JA, Davies NM. Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, pharmacokinetics and anti-cancer studies. J. Pharm. Pharmaceut. Sci. 8(3), 374-386 (2005). A simple HPLC method was developed for the determination of rhapontigenin. The assay was successfully applied to both the in vitro and in vivo metabolic kinetic study of rhapontigenin.
38. Kageura T, Matsuda H, Morikawa T et al. Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg. Med. Chem. 9(7), 1887-1893 (2001).
39. Cheong H, Ryu SY, Kim KM. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med. 65(3), 266-268 (1999).
40. Aburjai TA. Anti-platelet stilbenes from the aerial parts of Rheum palaestinum. Phytochemistry 55(5), 407-410 (2000).
41. Chun YJ, Ryu SY, Jeong TC, Kim MY. Mechanism-based inhibition of human Cytochrome P450 1A1 by rhapontigenin. Drug Met. Disp. 29(4), 389-393 (2001). Rhapontigenin is a potent mechanism-based inactivator of human P450 1A1 and may be considered as a good candidate for a cancer chemopreventive agent in humans.
42. Guengerich FP, Chun Y, Kim D, Gilliam EMJ, Shimada T. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mut. Res. 523-524(1-2),173-182 (2003).
43. Roupe KA, Yáñez JA, Teng XW, Davies NM. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. J. Pharm. Pharmacol. 58(11), 1443-1450 (2006). Rhapontigenin was highly distributed into tissues and were highly extracted by the liver. The estimates of oral bioavailability characterize rhapontigenin as poorly bioavailable compounds.
44. Sale S, Verschoyle RD, Boocock D et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene. Brit. J. Cancer 90(3), 736-744 (2004).
45. Lee GM, Lee HJ. KR 2002088243 (2002).